Biotech Pharma Limited

Abstract

The case illustrates a situation where the company had to decide on whether to discontinue production of its main product. The decision is influenced by government policy changes, international competition, and efficiency of the company's operations. The case has conceptual focus on elements of manufacturing strategy, especially in relation to international competitiveness, and uses elements of costs and its comparisons with international levels to identify strategic thrusts.